Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?

Dendritic cell (DC) based cancer immunotherapy aims at the activation of the immune system, and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the tumor. DCs represent a heterogeneous cell population, including conventional DCs (cDCs), consisting of cDC1s, cDC2s, plasmacyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Anne, Dammeijer, Floris, Aerts, Joachim G. J. V., Vroman, Heleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287551/
https://www.ncbi.nlm.nih.gov/pubmed/30559743
http://dx.doi.org/10.3389/fimmu.2018.02804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287551/
https://www.ncbi.nlm.nih.gov/pubmed/30559743
http://dx.doi.org/10.3389/fimmu.2018.02804

Ejemplares similares